Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 3/20 | 0.60 |
| ▸ | MMP8 | P22894 | 3/20 | 0.60 |
| ▸ | MMP1 | P03956 | 2/20 | 0.60 |
| ▸ | TERT | O14746 | 2/20 | 0.59 |
| ▸ | ACHE | P22303 | 9/20 | 0.59 |
| ▸ | BCHE | P06276 | 8/20 | 0.59 |
| ▸ | MMP7 | P09237 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | MPO | P05164 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.57 |
| ▸ | MMP9 | P14780 | 1/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17941647 | 1.00 | MMP2 (0.60) | MMP2MMP8MMP1TERTACHE | |
| SCHEMBL20281025 | 1.00 | MMP2 (0.60) | MMP2MMP8MMP1TERTACHE | |
| SCHEMBL10548878 | 1.00 | MMP2 (0.60) | MMP2MMP8MMP1TERTACHE | |
| SCHEMBL20657707 | 1.00 | MMP2 (0.60) | MMP2MMP8MMP1TERTACHE | |
| SCHEMBL20657708 | 1.00 | MMP2 (0.60) | MMP2MMP8MMP1TERTACHE | |
| SCHEMBL25080947 | 0.95 | KDM4E (0.61) | TERTACHEBCHEKDM4EMEN1 | |
| SCHEMBL27163831 | 0.95 | KDM4E (0.61) | TERTACHEBCHEKDM4EMEN1 | |
| SCHEMBL30812923 | 0.95 | KDM4E (0.61) | TERTACHEBCHEKDM4EMEN1 | |
| Hydrochloric Acid SCHEMBL21082975 | 0.93 | ACHE (0.65) | TERTACHEBCHEKDM4EMEN1 | |
| Hydrochloric Acid SCHEMBL21082961 | 0.93 | ACHE (0.65) | TERTACHEBCHEKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0558648-B1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GALARDY RICHARD E (US) | 2004-04-28 | — | — | EP | disclosed |
| EP-0663823-B1 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED INC (US) | 2000-11-22 | — | — | EP | disclosed |
| US-5892112-A | ACYLATION OF AMINO ACIDS WITH ANHYDRIDES OR CARBOXY GROUPS, AMIDATION WITH AMINE AND CONVERSION OF ACID OR ESTER TO HYDROXAMIC ACID AND HYDROLYSIS | GLYCOMED INCORPORATED (US) | 1999-04-06 | — | — | US | disclosed |
| US-5773438-A | SKIN DISORDERS, RESTENOSIS, RHEUMATIC ARTHRITIS, WOUND HEALING AGENTS, ANGIOGENESIS, SHOCK | GLYCOMED INCORPORATED (US) | 1998-06-30 | — | — | US | disclosed |
| EP-0558681-B1 | TREATMENT FOR TISSUE ULCERATION | UNIV FLORIDA (US) | 1998-04-08 | — | — | EP | disclosed |
| US-5696147-A | CONTROLLING GROWTH OF TUMORS AND NEOVASCULAR GLAUCOMAS | GLYCOMED, INC. (US) | 1997-12-09 | — | — | US | disclosed |
| EP-0558635-B1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED INC (US) | 1997-09-10 | — | — | EP | disclosed |
| EP-0663823-A4 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS. | GLYCOMED INC (US) | 1997-06-04 | — | — | EP | disclosed |
| EP-0692931-A4 | SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS AND USES THEREOF | GLYCOMED INC (US) | 1996-03-20 | — | — | EP | disclosed |
| EP-0690841-A4 | SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS AND USES THEREOF | GLYCOMED INC (US) | 1996-03-13 | — | — | EP | disclosed |
| EP-0558648-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GALARDY, Richard, E. (US) | 1993-09-08 | — | — | EP | disclosed |
| US-5239078-A | Collagenase enzyme inhibitors | GLYCOMED INCORPORATED (US) | 1993-08-24 | — | — | US | disclosed |
| WO-1993013741-A2 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED, INC. (US) | 1993-07-22 | — | — | WO | disclosed |
| US-5189178-A | Preventing protein destruction | GALARDY RICHARD E (US) | 1993-02-23 | — | — | US | disclosed |
| US-5183900-A | Matrix metalloprotease inhibitors | GALARDY RICHARD E (US) | 1993-02-02 | — | — | US | disclosed |
| WO-1992009563-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED, INC. (US) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009556-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GALARDY RICHARD E (US) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009282-A1 | TREATMENT FOR TISSUE ULCERATION | THE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 1992-06-11 | — | — | WO | disclosed |
| US-5114953-A | Peptides | UNIVERSITY OF FLORIDA (US) | 1992-05-19 | — | — | US | disclosed |
| US-4831038-A | ANTITUMOR ALKALOIDS | IRE-CELLTARG S.A. (BE) | 1989-05-16 | — | — | US | disclosed |